flecainide acetate , a new class 1 agent , was therefore administered both intravenously and orally to 13 patients with recurrent paroxysmal tachycardia to assess whether the acute response to intravenous flecainide accurately predicts the response to oral therapy .
C0086303
flecainide acetate
C0016229
flecainide